Published in Lancet on November 27, 1999
A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat Genet (2010) 6.62
Phenotypic variability and genetic susceptibility to genomic disorders. Hum Mol Genet (2010) 2.57
Patterns of dysmorphic features in schizophrenia. Am J Med Genet (2001) 1.03
A 4q35.2 subtelomeric deletion identified in a screen of patients with co-morbid psychiatric illness and mental retardation. BMC Med Genet (2004) 0.92
Prenatal isolated mild ventriculomegaly is associated with persistent ventricle enlargement at ages 1 and 2. Early Hum Dev (2012) 0.85
Impaired cognition and attention in adults: pharmacological management strategies. Neuropsychiatr Dis Treat (2007) 0.83
Reduced cortical thickness in mental retardation. PLoS One (2011) 0.81
Subarachnoid space: new tricks by an old dog. PLoS One (2012) 0.80
Cerebral biometry at birth and at 4 and 8 months of age. A prospective study using US. Pediatr Radiol (2010) 0.80
Mental health services for people with learning disabilities. People with comorbidity can fall between two stools. BMJ (2001) 0.75
Childhood antecedents of schizophrenia and affective illness: social adjustment at ages 7 and 11. BMJ (1994) 3.33
Cerebral ventricular size and cognitive impairment in chronic schizophrenia. Lancet (1976) 3.14
Magnetic resonance imaging of brain in people at high risk of developing schizophrenia. Lancet (1999) 2.47
Structural disconnectivity in schizophrenia: a diffusion tensor magnetic resonance imaging study. Br J Psychiatry (2003) 2.31
Lupus susceptibility loci in New Zealand mice. Proc Natl Acad Sci U S A (1994) 2.12
CT measurements of lung density in life can quantitate distal airspace enlargement--an essential defining feature of human emphysema. Am Rev Respir Dis (1988) 2.06
Presenilin-I, presenilin-II, and VLDL-R associations in early onset Alzheimer's disease. Lancet (1997) 2.06
Complications of pregnancy and delivery in relation to psychosis in adult life: data from the British perinatal mortality survey sample. BMJ (1991) 2.03
Service provision for people with schizophrenia. II. Role of the general practitioner. Br J Psychiatry (1997) 1.88
Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users. Br J Psychiatry (1999) 1.86
The dementia of dementia praecox. Acta Psychiatr Scand (1978) 1.79
The Northwick Park electroconvulsive therapy trial. Lancet (1981) 1.79
Postmortem evidence of structural brain changes in schizophrenia. Differences in brain weight, temporal horn area, and parahippocampal gyrus compared with affective disorder. Arch Gen Psychiatry (1986) 1.74
Schizophrenic patients discharged from hospital--a follow-up study. Br J Psychiatry (1984) 1.71
Measurement of CT lung density in patients with chronic asthma. Eur Respir J (1997) 1.71
Dangerous behaviour preceding first admissions for schizophrenia. Br J Psychiatry (1992) 1.71
The effects of a neuregulin 1 variant on white matter density and integrity. Mol Psychiatry (2007) 1.68
Acetylator status and response to phenelzine in depressed patients. Lancet (1973) 1.67
Neurotic illness and its response to anxiolytic and antidepressant treatment. Psychol Med (1980) 1.66
Brain structure, genetic liability, and psychotic symptoms in subjects at high risk of developing schizophrenia. Biol Psychiatry (2001) 1.59
The role of computed tomographic examination of the pelvis in the management of testicular germ cell tumours. Clin Radiol (1997) 1.56
New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet (1997) 1.55
A MRI study of ocular hypertelorism in individuals at high risk of developing schizophrenia. Schizophr Res (2001) 1.54
Neuropsychological change in young people at high risk for schizophrenia: results from the first two neuropsychological assessments of the Edinburgh High Risk Study. Psychol Med (2000) 1.52
Concordance by sex in sibling pairs with schizophrenia is paternally inherited. Evidence for a pseudoautosomal locus. Br J Psychiatry (1989) 1.50
The varying impact of type, timing and frequency of exposure to childhood adversity on its association with adult psychotic disorder. Psychol Med (2010) 1.49
Unsuspected organic disease in chronic schizophrenia demonstrated by computed tomography. J Neurol Neurosurg Psychiatry (1980) 1.48
Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet (1978) 1.47
The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol (2012) 1.46
Spontaneous involuntary disorders of movement: their prevalence, severity, and distribution in chronic schizophrenics with and without treatment with neuroleptics. Arch Gen Psychiatry (1982) 1.44
Magnetic resonance imaging of the brain in alcoholics: cerebral atrophy, lifetime alcohol consumption, and cognitive deficits. Alcohol Clin Exp Res (1989) 1.43
Small intestine permeability in schizophrenia. Br J Psychiatry (1989) 1.41
Schizophrenia as an anomaly of development of cerebral asymmetry. A postmortem study and a proposal concerning the genetic basis of the disease. Arch Gen Psychiatry (1989) 1.38
The Northwick Park Study of first episodes of schizophrenia. I. Presentation of the illness and problems relating to admission. Br J Psychiatry (1986) 1.36
Computed tomography of abdomen in staging and clinical management of lymphoma. Br Med J (1978) 1.34
Neuropsychological assessment of young people at high genetic risk for developing schizophrenia compared with controls: preliminary findings of the Edinburgh High Risk Study (EHRS). Psychol Med (1999) 1.34
Deficits in facial, body movement and vocal emotional processing in autism spectrum disorders. Psychol Med (2010) 1.33
Cumulative social disadvantage, ethnicity and first-episode psychosis: a case-control study. Psychol Med (2008) 1.32
Comparative trial of L-tryptophan and amitriptyline in depressive illness. Psychol Med (1976) 1.32
Ethnicity, social disadvantage and psychotic-like experiences in a healthy population based sample. Acta Psychiatr Scand (2008) 1.29
A randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry (1986) 1.27
Individualized prediction of illness course at the first psychotic episode: a support vector machine MRI study. Psychol Med (2011) 1.25
Lung CT density correlates with measurements of airflow limitation and the diffusing capacity. Eur Respir J (1991) 1.24
Brain abnormalities demonstrated by magnetic resonance imaging in adult IDDM patients with and without a history of recurrent severe hypoglycemia. Diabetes Care (1997) 1.20
Volumetric magnetic resonance imaging study of the brain in subjects with sex chromosome aneuploidies. J Neurol Neurosurg Psychiatry (1999) 1.20
fMRI correlates of state and trait effects in subjects at genetically enhanced risk of schizophrenia. Brain (2004) 1.20
Myocardial involvement in systemic lupus erythematosus detected by magnetic resonance imaging. Eur Heart J (1988) 1.18
The relationship between acetylator status and inhibition of monoamine oxidase, excretion of free drug and antidepressant response in depressed patients on phenelzine. Psychopharmacologia (1976) 1.15
'Pfropfschizophrenie' revisited. Schizophrenia in people with mild learning disability. Br J Psychiatry (1998) 1.14
Antinuclear antibodies in psychiatric illness: their relationship to diagnosis and drug treatment. Br Med J (1975) 1.13
Diffusion tensor imaging (DTI) and proton magnetic resonance spectroscopy (1H MRS) in schizophrenic subjects and normal controls. Psychiatry Res (2001) 1.12
Genetic liability, illicit drug use, life stress and psychotic symptoms: preliminary findings from the Edinburgh study of people at high risk for schizophrenia. Soc Psychiatry Psychiatr Epidemiol (2001) 1.12
Comparative trial of L-tryptophan and E.C.T. in severe depressive illness. Lancet (1974) 1.11
Edinburgh high risk study--findings after four years: demographic, attainment and psychopathological issues. Schizophr Res (2000) 1.10
Computed tomography (CT) in the staging of patients with Hodgkin's Disease: a report on 136 patients. Clin Radiol (1980) 1.10
Association of the mu-opioid receptor gene with smoking cessation. Pharmacogenomics J (2007) 1.09
Prevalence of psychiatric morbidity among remand prisoners in Scotland. Br J Psychiatry (1995) 1.09
Genetic variation in the dopamine D4 receptor (DRD4) gene and smoking cessation: follow-up of a randomised clinical trial of transdermal nicotine patch. Pharmacogenomics J (2007) 1.08
The Northwick Park "functional" psychosis study: diagnosis and treatment response. Lancet (1988) 1.07
Characterisation of acute myocardial infarction by gated magnetic resonance imaging. Lancet (1985) 1.07
A diffusion tensor MRI study of white matter integrity in subjects at high genetic risk of schizophrenia. Schizophr Res (2008) 1.06
Characteristics of patients with schizophrenia or neurological disorder and virus-like agent in cerebrospinal fluid. Lancet (1979) 1.06
Clinical correlates of postmortem brain changes in schizophrenia: decreased brain weight and length correlate with indices of early impairment. J Neurol Neurosurg Psychiatry (1994) 1.06
Neurodevelopmental indices and the development of psychotic symptoms in subjects at high risk of schizophrenia. Br J Psychiatry (2001) 1.05
Brain water measured by magnetic resonance imaging. Correlation with direct estimation and changes after mannitol and dexamethasone. Lancet (1987) 1.05
Criminality and antisocial behaviour in unselected men with sex chromosome abnormalities. Psychol Med (1999) 1.04
Set shifting and reversal learning in patients with bipolar disorder or schizophrenia. Psychol Med (2008) 1.01
Life events in suicide and undetermined death in south-east Scotland: a case-control study using the method of psychological autopsy. Soc Psychiatry Psychiatr Epidemiol (1999) 1.00
Lateral ventricular size in schizophrenia: relationship to the disease process and its clinical manifestations. Psychol Med (1985) 0.99
The occurrence of organic disease of possible or probable aetiological significance in a population of 268 cases of first episode schizophrenia. Psychol Med (1987) 0.99
The disabilities of chronic schizophrenia--their nature and the factors contributing to their development. Br J Psychiatry (1980) 0.99
Theory of mind and psychoses. Psychol Med (1998) 0.99
Methodological issues in volumetric magnetic resonance imaging of the brain in the Edinburgh High Risk Project. Psychiatry Res (1999) 0.98
Qualitative cerebral morphology in schizophrenia: a magnetic resonance imaging study and systematic literature review. Schizophr Res (1997) 0.98
Group psychological treatment for chest pain with normal coronary arteries. QJM (1999) 0.97
The spectrum of structural brain changes in schizophrenia: age of onset as a predictor of cognitive and clinical impairments and their cerebral correlates. Psychol Med (1989) 0.97
Serial changes in the T1 magnetic relaxation parameter after myocardial infarction in man. Br Heart J (1988) 0.97
The installation of a commercial resistive NMR imager. Br J Radiol (1984) 0.97
Childhood behaviour, psychotic symptoms and psychosis onset in young people at high risk of schizophrenia: early findings from the edinburgh high risk study. Psychol Med (2002) 0.96
The relationship of anterior thalamic radiation integrity to psychosis risk associated neuregulin-1 variants. Mol Psychiatry (2009) 0.96